A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1690, Issue 3, 2004, Pages 238-249

  Buckland, Paul R ^a   Hoogendoorn, Bastiaan ^a   Guy, Carol A ^a   Coleman, Sharon L ^a   Smith, S Kaye ^a   Buxbaum, Joseph D ^b   Haroutunian, Vahram ^b,c   O'Donovan, Michael C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HSPA1B; LMO4; NEFL; NPY; PCSK1; TF

Indexed keywords

ARTICLE; CELL LINE; DNA POLYMORPHISM; GENE EXPRESSION; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SCHIZOPHRENIA;

BASE SEQUENCE; BRAIN; GENE EXPRESSION REGULATION; GENES, REPORTER; HAPLOTYPES; HUMANS; INTERNET; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 7044231595     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.06.023     Document Type: Article

References (35)

1. Y. Hakak, J.R. Walker, C. Li, W.H. Wong, K.L. Davis, J.D. Buxbaum, V. Haroutunian, and A.A. Fienberg Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia Proc. Natl. Acad. Sci. 98 2001 4746 4751
2. K.V. Chowdari, K. Mirnics, P. Semwal, J. Wood, E. Lawrence, T. Bhatia, S.N. Deshpande, B.K. Thelma, R.E. Ferrell, F.A. Middleton, B. Devlin, P. Levitt, D.A. Lewis, and V.L. Nimgaonkar Association and linkage analyses of RGS4 polymorphisms in schizophrenia Hum. Mol. Genet. 11 2002 1373 1380
3. K.M. Druey, K.J. Blumer, V.K. Kang, and J.H. Kehrl Inhibition of G protein-mediated MAP kinase activation by a new mammalian gene family Nature 379 1996 742 746
4. L.M. Brustowicz, K.A. Hodgkinson, E.W. Chow, W.G. Honer, and A.S. Bassett Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22 Science 288 2000 678 682
5. Y. Horikawa, N. Oda, N.J. Cox, X. Li, M. Orho-Melander, M. Hara, Y. Hinokio, T.H. Lindner, H. Mashima, P.E. Schwarz, L. del Bosque-Plata, Y. Horikawa, Y. Oda, I. Yoshiuchi, S. Colilla, K.S. Polonsky, S. Wei, P. Concannon, N. Iwasaki, J. Schulze, L.J. Baier, C. Bogardus, L. Groop, E. Boerwinkle, C.L. Hanis, and G.I. Bell Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus Nat. Genet. 26 2000 163 175
6. J.D. Rioux, M.J. Daly, M.S. Silverberg, K. Lindblad, H. Steinhart, Z. Cohen, and T. Delmonte Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease Nat. Genet. 29 2001 223 228
7. R.E. Straub, Y. Jiang, C.J. Maclean, Y. Ma, B.T. Webb, M.V. Myakishev, C. Harris-Kerr, B. Wormley, H. Sadek, B. Kadambi, A.J. Cesare, A. Gibberman, X. Wang, F.A. O'Neill, D. Walsh, and K.S. Kendler Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene is associated with schizophrenia Am. J. Hum. Genet. 71 2002 337 348
8. H. Stefansson, E. Sigurdsson, V. Steinthorsdottir, S. Bjornsdottir, T. Sigmundsson, S. Ghosh, J. Brynjolfsson, S. Gunnarsdottir, O. Ivarsson, T.T. Chou, O. Hjaltason, B. Birgisdottir, H. Jonsson, V.G. Gudnadottir, E. Gudmundsdottir, A. Bjornsson, B. Ingvarsson, A. Ingason, S. Sigfusson, H. Hardardottir, R.P. Harvey, D. Lai, M. Zhou, D. Brunner, V. Mutel, A. Gonzalo, G. Lemke, J. Sainz, G. Johannesson, T. Andresson, D. Gudbjartsson, A. Manolescu, M.L. Frigge, M.E. Gurney, A. Kong, J.R. Gulcher, H. Petursson, and K. Stefansson Neuregulin 1 and susceptibility to schizophrenia Am. J. Hum. Genet. 71 2002 877 892
9. H. Stefansson, J. Sarginson, A. Kong, P. Yates, V. Steinthorsdottir, E. Gudfinnsson, S. Gunnarsdottir, N. Walker, H. Petursson, C. Crombie, A. Ingason, J.R. Gulcher, K. Stefansson, and D. St. Clair Association of neuregulin 1 with schizophrenia confirmed in a Scottish population Am. J. Hum. Genet. 72 2003 83 87
10. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, and D.B. Rainbow Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 2003 506 511
11. A. Suzuki, R. Yamada, X. Chang, S. Tokuhiro, T. Sawada, M. Suzuki, M. Nagasaki, M. Nakayama-Hamada, R. Kawaida, M. Ono, M. Ohtsuki, H. Furukawa, S. Yoshino, M. Yukioka, S. Tohma, T. Matsubara, S. Wakitani, R. Teshima, Y. Nishioka, A. Sekine, A. Iida, A. Takahashi, T. Tsunoda, Y. Nakamura, and K. Yamamoto Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat. Genet. 34 2003 395 402
12. M. Levine, and R. Tjian Transcription regulation and animal diversity Nature 424 2003 147 151
13. G. Yvert, R.B. Brem, J. Whittle, J.M. Akey, E. Foss, E.N. Smith, R. Mackelprang, and L. Kruglyak Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factors Nat. Genet. 35 2003 57 64
14. E.E. Schadt, S.A. Monks, T.A. Drake, A.J. Lusis, N. Che, V. Colinayo, T.G. Ruff, S.B. Milligan, J.R. Lamb, G. Cavet, P.S. Linsley, M. Mao, R.B. Stoughton, and S.H. Friend Genetics of gene expression surveyed in maize, mouse and man Nature 422 2003 297 301
15. H. Yan, W. Yuan, V.E. Velculescu, B. Vogelstein, and K.W. Kinzler Allelic variation in human gene expression Science 297 2003 1143
16. N.J. Bray, P.R. Buckland, N.M. Williams, H.J. Williams, N. Norton, M.J. Owen, and M.C. O'Donovan A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain Am. J. Hum. Genet. 73 2003 152 161
17. B. Hoogendoorn, S.L. Coleman, C.A. Guy, K. Smith, T. Bowen, P.R. Buckland, and M.C. O'Donovan Functional analysis of human promoter polymorphisms Hum. Mol. Genet. 12 2003 2249 2254
18. V. Praz, R.C. Périer, C. Bonnard, and P. Bucher The Eukaryotic Promoter Database, EPD: new entry types and links to gene expression data Nucleic Acids Res. 30 2002 322 324
19. K.L. Davis, D.G. Stewart, J.I. Friedman, M. Buchsbaum, P.D. Harvey, P.R. Hof, J. Buxbaum, and V. Haroutunian White matter changes in schizophrenia Arch. Gen. Psychiatry 60 2003 443 456
20. S.L. Coleman, P.R. Buckland, B. Hoogendoorn, C. Guy, K. Smith, and M.C. O'Donovan A streamlined approach to functional analysis of promoter region polymorphisms BioTechniques 33 2002 412 418
21. N.D. Trinklein, S.J.F. Aldred, A.J. Saldanha, and R.M. Myers Identification and functional analysis of human transcriptional promoters Genome Res. 13 2003 308 312
22. S. Rozen, H.J. Kaletsky, Primer3 (1998). Code available at http://www.genome.wi.mit.edu/genome_software/other/primer3.html.
23. T.W. Burke, and J.T. Kadonaga The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila Genes Dev. 11 1997 3020 3031
24. A.C. Jones, J. Austin, N. Hansen, B. Hoogendoorn, P.J. Oefner, J.P. Cheadle, and M.C. O'Donovan Optimal temperature selection for mutation detection by denaturing high performance liquid chromatography and comparison to SSCP and heteroduplex analysis Clin. Chem. 45 1999 1133 1140
25. S.L. Coleman, P.R. Buckland, B. Hoogendoorn, C. Guy, K. Smith, and M.C. O'Donovan Experimental analysis of the annotation of promoters in the public database Hum. Mol. Genet. 11 2002 1817 1821
26. R. Liu, and D.J. States Consensus promoter identification in human genome utilizing expressed sequence markers and gene modelling Genome Res. 12 2002 462 469
27. M.C. Frith, U. Hansen, and Z. Weng Detection of cis-element clusters in higher eukaryotic DNA Bioinformatics 17 2001 878 889
28. E. Wingender, X. Chen, R. Hehl, H. Karas, I. Liebich, V. Matys, T. Meinhardt, M. Pruss, I. Reuter, and F. Schacherer TRANSFAC: an integrated system for gene expression regulation Nucleic Acids Res. 28 2000 316 319
29. N. Grabe AliBaba2: context specific identification of transcription factor binding sites Silico. Biol. 2 2002 S1-1
30. V.B. Bajic, S.H. Seah, A. Chong, S.P.T. Krishnan, J.L.Y. Koh, and V. Brusic Computer model for recognition of functional transcription start sites in polymerase II promoters of vertebrates J. Mol. Graph. Model. 21 2003 323 332
31. K. Sakai, K. Maeda, K. Chihara, and H. Kaneda Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats Neuropeptides 29 1995 157 161
32. S.M. Gabriel, M. Davidson, V. Haroutunian, P. Powchik, L.M. Bierer, D.P. Purohit, D.P. Perl, and K.L. Davis Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex Biol. Psychiatry 39 1996 82 91
33. D. De Wied, and H.O. Sigling Neuropeptides involved in the pathophysiology of schizophrenia and major depression Neurotox. Res. 4 2002 453 468
34. S. Iritani, N. Kuroki, K. Niizato, and K. Ikeda Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 2000 241 249
35. M. Itokawa, M. Arai, S. Kato, Y. Ogata, A. Furukawa, S. Haga, H. Ujike, I. Sora, K. Ikeda, and T. Yoshikawa Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans Neurosci. Lett. 347 2003 202 204